The Non-Covalent Oncology Paradigm: Jaypirca's Frontline Infiltration and the BTK Landscape
Dr. Dereck Mush, MD, MBALife sciences
Pharma, biology platforms, drug discovery and the science that turns lab work into therapies and products.
Dr. Dereck Mush, MD, MBA
Molecular Cardioprotection: How Pediatric Myosin Inhibition Redefines the Economics of Congenital Heart Care
Dr. Dereck Mush, MD, MBA
The D1/D5 Bet: What AbbVie's Juvmo Adds to Parkinson's Care
Dr. Dereck Mush, MD, MBA
The ALK2 Opening: What Atebrioz Means for Rare Bone Disease
Dr. Dereck Mush, MD, MBA
